Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

CEBP Focus: Update on Lymphoma

Sun Exposure and Non-Hodgkin Lymphoma

Bruce K. Armstrong and Anne Kricker
Bruce K. Armstrong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Kricker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-06-1068 Published March 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

It was initially hypothesized that sun exposure might cause non-Hodgkin lymphoma (NHL) on the following grounds: its incidence was increasing in parallel with that of cutaneous melanoma; its risk was increased in those with a history of melanoma or other skin cancer; sun exposure causes immune suppression; and immunosuppression for other reasons is associated with an increased risk of NHL. The association of NHL with prior skin cancer has been found consistently in subsequent studies, but results of ecological analyses have only partially supported this hypothesis. Contrary to it, three recent studies of NHL in individuals found that risk decreased, generally by 25% to 40%, across categories of increasing total or recreational, but not occupational, sun exposure. One study, thus far reported only in abstract, showed the opposite. Production of vitamin D from sun exposure offers a plausible mechanism for protection against NHL by sun exposure. A recent study has found a reduced risk of NHL in people with a high dietary intake of vitamin D. Results of additional studies in individuals and a planned original-data meta-analysis of case-control studies should help to resolve the present conflicting results on sun exposure and NHL. (Cancer Epidemiol Biomarkers Prev 2007;16(3):396–400)

  • non-Hodgkin lymphoma
  • risk
  • case-control
  • sun exposure
  • UV radiation

Introduction

Zheng et al. (1) first suggested that sun exposure might increase risk of non-Hodgkin lymphoma (NHL) on the following grounds: its incidence had increased in parallel with that of cutaneous melanoma in Connecticut from 1935 to 1939 to 1985 to 1988; risk of NHL had been reported to be increased in people with a history of skin cancer; sun exposure had been shown to have immune suppressant effects; and risk of NHL was increased in people with AIDS or receiving immune suppressant therapy. Support for this hypothesis was soon offered by Cartwright et al. (2) who reported a significant positive correlation between incidence of NHL and incidence of nonmelanocytic skin cancer in nine cancer registries worldwide that recorded both, and a weaker correlation between temporal trends in both.

With publication since 2004 of results in individuals that suggest that sun exposure might protect against NHL (3), a review of the relevant literature is timely.

Materials and Methods

The National Center for Biotechnology Information PubMed online index of biomedical articles was searched for relevant publications using the following syntax: (“lymphoma/epidemiology” [MeSH Terms] OR “lymphoma/etiology” [MeSH Terms]) AND (“ultraviolet rays” [MeSH Terms] OR “sunlight” [MeSH Terms]). Additional informative publications were found in the bibliographies of relevant articles found in the initial search. Only studies dealing with NHL as a whole were reviewed; a small literature on UV radiation and cutaneous lymphoma has not been reviewed. Because of the brief communication format of this study, not all relevant studies are referred to.

Results

NHL Risk Higher with a History of Skin Cancer

In 1995, Adami et al. (4) reported that the relative risk for NHL was 2.0 [95% confidence interval (95% CI), 1.7-2.4] in those with a prior Danish Cancer Registry record of nonmelanocytic skin cancer; it was rather less in those with a prior cutaneous melanoma (relative risk, 1.4; 95% CI, 1.1-1.7). These associations had been observed in some smaller, preceding studies and have been consistently found in subsequent similar studies (see, e.g., ref. 5), including a meta-analysis that found a relative risk of 2.01 (95% CI, 1.79-2.24) for NHL following melanoma (6). Although the risk for NHL is significantly increased following diagnosis of any cancer, it is particularly increased following UV-related cancers (7). Shared genetic or environmental risk factors, particularly sun exposure, might explain associations between skin cancer and NHL; it has also been suggested that persistent suppressor T-cell activity or some other immunologic change initiated by the first tumor might increase risk of the second, independently of any shared etiology (6).

NHL Risk Varies with Ambient UV Irradiance

In response to Adami et al.'s article, Newton pointed out that incidence of NHL fell with increasing measured ambient UV in six U.S. populations for which data on both NHL and UV were available, the opposite of what would be expected if exposure to the sun increased NHL risk (8). Similar results were reported for NHL mortality and estimated UV irradiance in the United States (9). Findings inconsistent with these, however, were reported more or less simultaneously: Bentham reported that incidence of NHL increased significantly with increasing UV irradiance in 59 counties of England and Wales (10), and McMichael and Giles reported a significant overall positive correlation of NHL incidence in 1978 to 1987, with estimated ambient solar UVB in 49 populations of European origin in Europe, North America, and Oceania (11).

Figure 1 presents an up-to-date picture of these global geographic gradients based on data for 1993 to 1997 from 53 cancer registries with mainly European origin populations that had at least 500 incident cases of NHL in each sex in the period. Although an overall downtrend can be seen with increasing latitude (decreasing UV irradiance) in both sexes, this seems to be largely due to the relative positions of the United States (i.e., lower latitudes and higher NHL incidence rates) and Northern Europe (i.e., higher latitudes and lower NHL rates). The trends in NHL incidence with latitude varied among the five broad geographic regions shown. In females, uptrends and downtrends with latitude are more or less evenly balanced, whereas in males, there is a more, but not wholly, consistent downtrend with increasing latitude. It thus seems probable that ambient UV irradiance in not the main determinant of these trends, if a determinant at all.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Age-standardized (to World population) incidence of NHL plotted against latitude in 53 populations of mainly European origin (incidence data from ref. 26). Cancer registry populations included are Canada (Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Prince Edward Island, Quebec, Saskatchewan), United States (Los Angeles non-Hispanic White, San Francisco White, Connecticut White, Atlanta White, Hawaii White, Iowa, New Orleans White, Detroit White, New Mexico, Utah, Seattle), Northern Europe (Denmark, Finland, Germany Saarland, Norway, Sweden; Switzerland: Basel, Geneva, St Gall-Appenzell, Vaud, Zurich; The Netherlands Eindhoven; England: Mersey, North Western, Oxford, South Thames, West Midlands, Yorkshire; Scotland), Southern Europe (France; Bas-Rhin, Isere; Italy: Florence, Parma, Torino, Varese; Spain Zaragoza), Australia (New South Wales, South Australia, Tasmania, Victoria, Western Australia, Australian Capital Territory), and New Zealand.

NHL Risk Varies with Race and Migration

McMichael and Giles (11) reported that NHL risk on migration to Australia, a region of high ambient UV, from the United Kingdom, a region of low ambient UV, showed a similar but less pronounced pattern to that of melanoma. That is, risk was higher in people born in Australia than in those resident in the United Kingdom and risk in migrants lay between the two. The age-standardized incidence of NHL in Blacks in the United States is from 59% to 100% of that in Whites living in the same geographic region, depending on registry and sex. This pattern too is similar to that for melanoma but much less marked (Blacks, 3-16% of corresponding rates in Whites; ref. 12).

NHL Risk with Inferred Occupational Sun Exposure

Several studies in the United States and Sweden have examined incidence or mortality of NHL in relation to occupational sun exposure, generally classified from the job title and only in men (13-16). We did a simple, fixed-effects meta-analysis of the results in men treating “low” and “indoor,” “medium” and “mixed,” and “high” and “outdoor” as equivalent and combining the second and third exposure categories of van Wijngaarden and Savitz (16) as medium and the fourth and fifth as high. Relative to 1 for low occupational sun exposure, the relative risk for medium exposure was 0.98 (95% CI, 0.94-1.01) and that for high was 0.92 (95% CI, 0.88-0.96).

NHL Risk and Recalled Sun Sensitivity and Personal Sun Exposure

Three case-control studies initiated in the late 1990s and early 2000s have tested the hypothesis that sun sensitivity or sun exposure alters NHL risk: Hughes et al. reported results from an Australian population (refs. 3, 17; the New South Wales or NSW study); Smedby et al. reported from a large study in Sweden and Denmark (the Scandinavian Lymphoma Etiology or SCALE study; ref. 18, 19); and Hartge et al. reported from a U.S. study (the National Cancer Institute/Surveillance, Epidemiology, and End Results or NCI-SEER study; ref. 20).

Only in the NCI-SEER study was there a strong association between a sun-sensitivity characteristic and NHL (Table 1 ); risk was about 50% less in those with blue or blue-green eyes than in those with dark brown eyes. This result is statistically incompatible with weakly increased risks with roughly corresponding eye colors in the other two studies. The NSW study found increases in risk of about 50% for very fair skin, severe burn with blisters on acute sun exposure, and no tan or freckles only on repeated sun exposure, whereas the SCALE study found no increase in risk in people who always burn on acute sun exposure, and the NCI-SEER study reported a 25% reduction in risk with fair complexion, but with a wide confidence interval.

View this table:
  • View inline
  • View popup
Table 1.

Sun sensitivity characteristics and NHL in the NSW, SCALE and NCI-SEER case-control studies (3, 18)

All three studies found significant inverse associations between NHL risk and sun exposure (Table 2 ). Risk of NHL fell significantly with total sun exposure in the NSW study (estimated from recall of usual daytime outdoor hours on working and nonworking days in a typical week in the warmer and cooler months in decade years of age from age 10 to 60), and there was a similar but weaker and nonsignificant trend in the NCI-SEER study estimated in a similar way in several different periods of life. The NSW study trend was due entirely to a strong trend with exposure on nonworking days (Table 2). Apparently, protective effects of recreational or intermittent sun exposure are also indicated by results of the NSW and SCALE studies for vacation sun exposure: the SCALE study for sunbathing at 20 years of age and the SCALE and NCI studies for sunburn (Table 2). Neither exposure on working days (Table 2) nor exposure in all jobs held from 15 years of age (data not shown) was significantly associated with NHL risk in the NSW study. Risk of NHL in the SCALE study was increased slightly but significantly with occupational sun exposure [odds ratio (OR), 1.1; 95% CI, 1.0-1.2]. The NCI-SEER study found an inverse association with increasing ambient UV at all places of residence (OR, 0.76; 95% CI, 0.50-1.15; per 50 Robertson-Berger units increase in UV; ref. 20) as did the NSW study, with an OR of 0.76 (95% CI, 0.45-1.26) for the highest quarter of estimated lifetime average annual solar UVB irradiance,3 but neither was statistically significant. The apparent protective effect of sun exposure in the NSW study was greater in women than men and with exposure in early life, but the statistical significance of these apparent differences was not tested formally. Sun exposure effects in the NCI-SEER study were reported to be similar between the sexes and with different ages at exposure.

View this table:
  • View inline
  • View popup
Table 2.

Sun exposure and NHL in the NSW and SCALE case-control studies (3, 18)

Results of analyses of effects of sun exposure in another case-control study of NHL have been reported in abstract only. Increased risks of NHL were reported for the highest category of time spent in strong sunlight between 9 a.m. and 3 p.m. in summer (OR, 1.7; 95% CI, 1.2-2.5) and with having an outdoor occupation (OR, 1.8; 95% CI, 1.0-3.5). No protective effects of sun exposure were observed (21).

Discussion

Ecological evidence on the association between ambient UV irradiance and risk of NHL provides weak support for a causal rather than a protective relationship. Although incidence of NHL has increased in parallel with that of melanoma, for which the evidence of a causal connection to sun exposure is strong (19), factors other than a shared cause could produce such parallel trends. Studies of incidence by area of residence have produced conflicting patterns. Although increasing risk with migration from an area of low to one of high ambient UV is consistent with a causal effect of sun exposure, there is limited evidence of this pattern, and other explanations for it are possible, including selection for migration and health service factors that lead to differences in probability of diagnosis between the two areas. Ethnic differentials in risk in the United States are also compatible with a causal effect, but lifestyle and health service access differences are possible alternative explanations for them.

The evidence for a positive relationship between risk of skin cancer and risk of NHL is much more consistent than the evidence for a positive relationship between ambient UV and risk of NHL. An inference of causation from this association, however, is quite indirect. Other explanations are possible, but none have been proven or ruled out.

The data on individual sun exposure and risk of NHL are more consistent with a protective than a causal effect of sun exposure. There is, though, inconsistency in this evidence too. Specific occupational studies suggest a weak protective effect of sun exposure, but this has not been observed in studies that have included measures of both occupational and recreational sun exposure. Although recreational sun exposure was significantly protective in two studies, one incompletely reported study suggests the opposite. Moreover, there have been limited attempts thus far to rule out confounding as an explanation for the apparently protective associations. The SCALE results were adjusted for occupational exposure to pesticides, smoking, body mass, and history of autoimmune disorders, which have been reported as associated with NHL, but other possible confounders, such as diet, physical activity, and hormone use, and reproductive variables in women (the NSW association was stronger in women than men) have not been addressed. It would be wise, therefore, to reserve judgement on the current evidence for protective effects of recreational sun exposure until more results from studies in individuals are available, and possible confounding has been more thoroughly considered.

Is there any mechanism whereby sun exposure might protect against NHL? There is: vitamin D, the main source of which (said to be as much as 90% ref. 22) is cutaneous synthesis of the pro-vitamin under the influence of incident UVB radiation. There is some limited evidence that vitamin D can induce regression of low-grade NHL (23), and it has been shown to have antiproliferative and pro-differentiating effects in lymphoma cell lines, although at above physiologic concentrations (24). A recent study found a significant 40% reduction in risk of NHL from the lowest to the highest third of dietary intake of vitamin D (25). There was little evidence of this association, however, in the NCI-SEER study (20). Any certainty as to it must probably await results from studies of serum vitamin D and NHL nested in one or more of the large cohort studies.

As yet, there is inconsistent evidence for either a causal effect of sun exposure for, or a protective effect against, NHL. There are plausible biological mechanisms for either. In addition, if there is a protective effect, as three of four case-control studies suggest, it may not be large. For example, in the NCI-SEER data, 65% of controls had ≥7 h a week of sun exposure in the preceding 10 years, and the OR of NHL for this exposure was 0.78, which suggests a prevented fraction of 14%. There are complete but not yet published studies available, and there is an InterLymph4 initiative to pool their results with those that have been published already. The statistical power available from these studies, thorough consideration of confounding, and future possibilities of studying gene and environment interactions may help to reach a more certain position on sun exposure and NHL.

Footnotes

  • ↵3 Unpublished data.

  • ↵4 http://epi.grants.cancer.gov/InterLymph/

  • Grant support: National Health and Medical Research Council of Australia project grant 990920, The Cancer Council New South Wales, and a University of Sydney Medical Foundation program grant.

    • Accepted December 21, 2006.
    • Received December 19, 2006.

References

  1. ↵
    Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer 1992;70:840–9.
    OpenUrlCrossRefPubMed
  2. ↵
    Cartwright R, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 1994;14:387–94.
    OpenUrlPubMed
  3. ↵
    Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004;112:865–71.
    OpenUrlCrossRefPubMed
  4. ↵
    Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995;310:1491–5.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996;74:1847–50.
    OpenUrlPubMed
  6. ↵
    Lens MB, Newton-Bishop JA. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol 2005;16:460–5.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Brennan P, Coates M, Armstrong B, Colin D, Boffetta P. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 2000;82:1344–7.
    OpenUrlCrossRefPubMed
  8. ↵
    Newton R. Non-Hodgkin's lymphoma and skin cancer. American data refute ultraviolet hypothesis. BMJ 1995;311:750–1.
    OpenUrlPubMed
  9. ↵
    Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF, Jr. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 1996;88:298–300.
    OpenUrlFREE Full Text
  10. ↵
    Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ 1996;312:1128–31.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996;73:945–50.
    OpenUrlPubMed
  12. ↵
    Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Volume VII. Lyon: IARC; 1997.
  13. ↵
    Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 1997;314:1451–5.
    OpenUrlAbstract/FREE Full Text
  14. Adami J, Gridley G, Nyren O, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999;80:641–5.
    OpenUrlCrossRefPubMed
  15. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001;12:552–7.
    OpenUrlCrossRefPubMed
  16. ↵
    van Wijngaarden E, Savitz DA. Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 2001;43:548–53.
    OpenUrlCrossRefPubMed
  17. ↵
    Hughes AM, Armstrong BK, Vajdic CM, et al. Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 2004;110:429–34.
    OpenUrlCrossRefPubMed
  18. ↵
    Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005;97:199–209.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Gruber SB, Armstrong BK. Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: OUP; 2006. pp. 1196–229.
  20. ↵
    Hartge P, Lim U, Freedman DM, et al. Ultraviolet radiation, dietary vitamin D, risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006;17:1045–52.
    OpenUrlCrossRefPubMed
  21. ↵
    Zhang Y, Holford TR, Leaderer B, et al. Sun exposure and risk of non-Hodgkin's lymphoma in Connecticut women. American Association for Cancer Research Annual Meeting 2006.
  22. ↵
    Holick M. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004;79:362–71.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Raina V, Cunningham D, Gilchrist N, Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 1991;63:463–5.
    OpenUrlPubMed
  24. ↵
    Hickish T, Cunningham D, Colston K, et al. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993;68:668–72.
    OpenUrlPubMed
  25. ↵
    Polesel J, Talamini R, Montella M, et al. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 2006;17:713–8.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Volume VIII. Lyon: IARC; 2002.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 16 (3)
March 2007
Volume 16, Issue 3
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sun Exposure and Non-Hodgkin Lymphoma
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sun Exposure and Non-Hodgkin Lymphoma
Bruce K. Armstrong and Anne Kricker
Cancer Epidemiol Biomarkers Prev March 1 2007 (16) (3) 396-400; DOI: 10.1158/1055-9965.EPI-06-1068

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Sun Exposure and Non-Hodgkin Lymphoma
Bruce K. Armstrong and Anne Kricker
Cancer Epidemiol Biomarkers Prev March 1 2007 (16) (3) 396-400; DOI: 10.1158/1055-9965.EPI-06-1068
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Environmental and Behavioral Factors and the Risk of Non-Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy
  • Exposure to Solvents and Risk of Non-Hodgkin Lymphoma: Clues on Putative Mechanisms
Show more CEBP Focus: Update on Lymphoma
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement